e-Pharmacy: Global Markets

Report Highlights

The global e-pharmacy market should grow from $66.1 billion in 2020 to reach $178.4 billion by 2025 at a compound annual growth rate (CAGR) of 22.0% during the period of 2020-2025.

Report Scope:

This report includes a detailed study of global and regional markets for various types of drugs, therapeutic categories and geographies. Estimated values are based on manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars unadjusted for inflation.

Report Includes:

- 44 data tables
- An overview of the global e-pharmacy market within the industry
- Analyses of the global market trends, with data from 2019-2020, and projections of five-year compound annual growth rates (CAGRs) through 2025
- Estimation of the actual market size and revenue forecasts for global e-pharmacy industry, and market share analysis by type of drug and therapeutic category with major regions and countries involved
- Information on market growth drivers and opportunities, industry supply chain structure, regulatory landscape and technological advancements shaping the overall e-pharmacy industry
- Impact of COVID-19 on the pharmaceutical market for e-pharmacy technologies vs. the overall global economy
- Company profiles of the major listed e-pharmacy players, including Amazon Pharmacy, NetMeds, CVS Healthcare Corp., L Rowland & Co. (Retail) Ltd., Shop Apotheke Europe N.V., and Walgreen Boots Alliance

Summary:

Over the last decade, the pharmacy industry and the wider health care community have been engaged in the online purchase of medicines. The internet offers a variety of choices for people seeking medicines with or without a prescription, and many commentators have identified associated risks and benefits. While it is recognized that counterfeit medicines and the wider use of consumer medicines information on the internet are closely linked to the e-pharmacy services market, these issues fall outside the scope of this report. The material considered here reveals different perspectives on consumer motivation and experiences when buying medicines online. Negative perceptions of the supply of online medicines, such as the purchase of restricted medicines without a prescription, and the lack of information offered to supplement the product, are reflected here. While the benefits of 24/7 access and privacy appear to be well-founded, the cost benefits are more disputed.

Despite evidence that some illicit drug procurement is taking place online, research claims that dealers, family/friends and legitimate medical prescriptions remain the main sources of for this procurement. In addition, regulatory strategies—despite the cynicism that the internet could ever be regulated—appear to have had a positive impact on illicit and controlled substances. Adequate consumer “eHealth literacy” is needed in addition to effective regulation to minimize harm, but even the most recent research shows serious expertise deficits in the general population. Online pharmacy has a place in the future supply of medicines and the industry could explore its potential to provide cognitive services alongside medicines. Brick-and-mortar pharmacies should reflect on the value they add to the transaction to avoid losing the younger “wired” generation of future patients and caregivers. Over the last two to three decades, the internet has become a first-line source of information for many people on all aspects of life. Likewise, interest in online purchases of products, including medicines, has increased. This report and related data will describe a number of issues related to online pharmacy operations across the board, and will conclude with some ideas on future developments.

E-pharmacies offer a convenient and affordable way to purchase medicines. They can provide quick access to quality healthcare for patients in remote areas, particularly when coupled with teleconsultations. E-pharmacies offer a strong value proposition to doctors in rural areas. The increasing penetration of the internet has increased the adoption of e-pharmacies and can help patients purchase medicines that are not available locally, where smaller pharmacies may have a limited range of medicines in stock. In view of access, physicians are able to prescribe a wide range of medicines that enable them to provide better care.

 Chapter 1 Introduction
 Introduction
 Study Goals and Objectives
 Reasons for Doing This Study
 Scope of Report
 Methodology
 Geographic Breakdown
 Analysts Credentials
 BCC Custom Research
 Related BCC Research Reports
 Chapter 2 Summary and Highlights
 
Market Overview
 Chapter 3 Market and Technology Background
 
Background
 Regulations
 e-Pharmacies
 Benefits
 Online Pharmacy Services
 Analysis of Market Opportunities
 Rising Incidence of Chronic Diseases
 Increasing Healthcare Expenditures
 Increasing Adoption of Telemedicine
 Prevalence of Self-Care
 Well-Developed Markets
 Developing Markets
 Impact of COVID-19 on the e-Pharmacy Market
 Chapter 4 Market Breakdown by Type of Drug
 
Introduction
 Prescription Drugs
 Over the Counter Drugs
 Chapter 5 Market Breakdown by Therapeutic Category
 
Market Highlights
 Analgesics/Antipyretics
 Benefits and Risks
 Acetaminophen
 Nonsteroidal Anti-Inflammatory Drugs
 Opioids
 Antihistamine and Cough and Cold Drugs
 Antihistamines
 Cough and Cold Remedies
 Gastrointestinal Disorder Treatments
 Antacids
 H2 Blockers
 Proton Pump Inhibitors
 Dermatological Drugs
 Skincare and Dermatological Drugs
 Acne Treatments
 Psoriasis
 Oral Medical Care Products
 Oral Debriding Agents and Wound Cleansers
 Dental Caries Treatments
 Gum Disease Treatments
 Cold Sore Treatments
 Eye Care Products
 Dry Eye Treatments
 Ocular Allergy Symptoms
 Ocular/Eye Vitamins
 Eyelid Hygiene
 Contact Lens Solutions
 Dry Eye
 Smoking Cessation Products
 Nicotine Gum
 Nicotine Lozenges
 Nicotine Patches
 Dietary Supplements
 Eating Disorders
 Treatments for Vitamins and Mineral Deficiency
 Vitamins and Mineral Supplements (VMS)
 Dermatology Drugs
 Chapter 6 Market Breakdown by Region
 
Market Highlights
 North America
 United States
 Canada
 Europe
 United Kingdom
 Germany
 France
 Asia-Pacific
 Japan
 China
 India
 Australia
 Rest of the World
 Chapter 7 Company Profiles
 
ALTO
 AMAZON PHARMACY (AMAZON.COM)
 BLINK HEALTH
 CVS HEALTH CORP.
 CANDRUGSTORE
 CAPSULE
 CHEFAA
 CHEMIST WAREHOUSE
 CONTROLLED LABS
 DOCTORSOLVE
 DOCMORRIS N.V.
 ECHO
 GOODRX
 GIANT EAGLE PHARMACY
 HONEYBEE HEALTH
 JD HEALTH
 L ROWLAND & CO. RETAIL LTD. (ROWLANDS PHARMACY)
 LLOYDS PHARMACY
 MAIL MY PRESCRIPTIONS
 MEDEXPRESS
 MEDIHERZ
 MONCOINSANTE
 NETMEDS
 PHARMSTORE
 PHARMACY2U
 PHARMACY DIRECT
 PHARMACY ONLINE
 PILL PACK
 RITE AID CORP.
 SHOP APOTHEKE EUROPE N.V.
 SUPERDRUG STORES PLC
 WALGREEN BOOTS ALLIANCE
 ZUR ROSE GROUP


List Of Tables

 Summary Table : Global e-Pharmacy Market, by Type of Drug, Through 2025
 Table 1 : Global e-Pharmacy Market, by Type of Drug, Through 2025
 Table 2 : Global Prescription Drug Market, by Region, Through 2025
 Table 3 : Global Prescription Drug Market, by Therapeutic Category, Through 2025
 Table 4 : Global OTC Drug Market, by Region, Through 2025
 Table 5 : Global OTC Drug Market, by Therapeutic Category, Through 2025
 Table 6 : Global e-Pharmacy Market, by Therapeutic Category, Through 2025
 Table 7 : Global e-Pharmacy Market for Analgesics, by Region, Through 2025
 Table 8 : Global e-Pharmacy Market for Antihistamine and Cough and Cold Remedies, by Region, Through 2025
 Table 9 : Global e-Pharmacy Market for Gastrointestinal Products, by Region, Through 2025
 Table 10 : Global e-Pharmacy Market for Oral Medical Care Products, by Region, Through 2025
 Table 11 : Global e-Pharmacy Market for Eye Care Products, by Region, Through 2025
 Table 12 : Global e-Pharmacy Market for Smoking Cessation Products, by Region, Through 2025
 Table 13 : Global e-Pharmacy Market for Dietary Supplements, by Region, Through 2025
 Table 14 : Global e-Pharmacy Market for Dermatology Drugs, by Region, Through 2025
 Table 15 : Global e-Pharmacy Market, by Region, Through 2025
 Table 16 : North American e-Pharmacy Market, by Country, Through 2025
 Table 17 : North American e-Pharmacy Market, by Drug Type, Through 2025
 Table 18 : North American e-Pharmacy Market, by Therapeutic Category, Through 2025
 Table 19 : Most Common Chronic Conditions for Adults Aged 65+ Years, by Type
 Table 20 : Number of Individuals Impacted by Chronic Diseases, 2005-2030
 Table 21 : The U.S. e-Pharmacy Market, by Therapeutic Category, Through 2025
 Table 22 : The U.S. e-Pharmacy Market, by Drug Type, Through 2025
 Table 23 : European e-Pharmacy Market, by Country, Through 2025
 Table 24 : European e-Pharmacy Market, by Drug Type, Through 2025
 Table 25 : European e-Pharmacy Market, by Therapeutic Category, Through 2025
 Table 26 : Frequency of Cardiac Procedures in Germany, 2017
 Table 27 : Rising Geriatric Population in Germany, 2000-2030
 Table 28 : Healthcare Expenditures in Germany, 2016 and 2017
 Table 29 : German e-Pharmacy Market, by Therapeutic Category, Through 2025
 Table 30 : German e-Pharmacy Market, by Drug Type, Through 2025
 Table 31 : Healthcare Spending and Financing in France, 2005-2017
 Table 32 : Asia-Pacific e-Pharmacy Market, by Country, Through 2025
 Table 33 : Asia-Pacific e-Pharmacy Market, by Drug Type, Through 2025
 Table 34 : Asia-Pacific e-Pharmacy Market, by Therapeutic Category, Through 2025
 Table 35 : Japanese e-Pharmacy Market, by Therapeutic Category, Through 2025
 Table 36 : Japanese e-Pharmacy Market, by Drug Type, Through 2025
 Table 37 : Cancer Incidence and Mortality in China, by Cancer Site, 2018
 Table 38 : Chinese e-Pharmacy Market, by Therapeutic Category, Through 2025
 Table 39 : Chinese e-Pharmacy Market, by Drug Type, Through 2025
 Table 40 : Rest of the World e-Pharmacy Market, by Drug Type, Through 2025
 Table 41 : Rest of the World e-Pharmacy Market, by Therapeutic Category, Through 2025
 Table 42 : CVS Healthcare Corp.: Company Financials, by Segment, 2018-2019
 Table 43 : Walgreen Boots Alliance: Company Financials, by Segment, 2019-2020
  


List Of Figures

 Summary Figure : Global e-Pharmacy Market, by Type of Drug, 2019-2025
 Figure 1 : Global Projections for the Top Three Chronic Diseases, 2005-2030
 Figure 2 : Global Distribution of Deaths from Chronic Diseases, by Country Income Level, 2018
 Figure 3 : Rising Trends in Global Healthcare Spending, by Payor Type, 2015-2040
 Figure 4 : Growing Healthcare Expenditures in the U.S., 2006-2019
 Figure 5 : Healthcare Expenditure as a Share of GDP, by Country, 2018
 Figure 6 : Smartphone Ownership in Emerging Countries, 2017 and 2018
 Figure 7 : Wireless Data Traffic in the U.S., 2010-2018
 Figure 8 : Healthcare Expenditures in the U.S., 2015 and 2025
 Figure 9 : Number of Individuals Impacted by Chronic Diseases, 2005-2030
 Figure 10 : Rising Geriatric Population in Germany, 2000-2030
 Figure 11 : Healthcare Expenditures in Germany, 2016 and 2017
 Figure 12 : Healthcare Spending and Financing in France, 2005-2017
  


Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available